PET and PET/CT for Radiotherapy Planning

  • Sasa Mutic
Part of the Medical Radiology book series (MEDRAD)


Radiat Oncol Biol Phys Intensity Modulate Radiation Therapy Positron Emission Tomog Scanner Radiotherapy Treatment Planning Positron Emission Tomog 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Bailey DL (2003) Data acquisition and performance characterization in PET. In: Valk PE, Bailey DL, Townsend DW, Maisey MN (eds) Positron emission tomography: basic science and clinical practice. Springer, Berlin Heidelberg New York, pp 69–90Google Scholar
  2. Bailey DL, Karp JS, Surti S (2003) Physics and instrumentation in PET. In: Valk PE, Bailey DL, Townsend DW, Maisey MN (eds) Positron emission tomography: basic science and clinical practice. Springer, Berlin Heidelberg New York, pp 41–67Google Scholar
  3. Beyer T, Townsend DW, Brun T, Kinahan PE, Charron M, Roddy R et al. (2000) A combined PET/CT scanner for clinical oncology. J Nucl Med 41:1369–1379PubMedGoogle Scholar
  4. Biehl K, Kong F, Bradley J, Dehdashti F, Mutic S, Siegel B (2004) FDG-PET definition of gross target volume for radiotherapy on NSCLC: is the use of 40% threshold appropriate? Cancer J 10 (Suppl 1):36Google Scholar
  5. Bradley J, Thorstad WL, Mutic S, Miller TR, Dehdashti F, Siegel BA, Bosch W, Bertrand RJ (2004) Impact of FDG-PET on radiation therapy volume delineation in non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 59:78–86PubMedCrossRefGoogle Scholar
  6. Chao KSC, Bosch WR, Mutic S, Lewis JS, Dehdashti F, Mintun MA, Dempsey JF, Perez CA, Purdy JA, Welch MJ (2001) A novel approach to overcome hypoxic tumor resistance Cu-ATSM-guided intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys 49:1171–1182PubMedGoogle Scholar
  7. Cook GJ, Fogelman I, Maisey MN (1996) Normal physiological and benign pathological variations of 18-fluoro-2-deoxyglucose positron-emission tomography scanning: potential for error in interpretation. Semin Nucl Med 26:308–314PubMedGoogle Scholar
  8. Defrise M, Kinahan PE, Michel C (2003) Image reconstruction algorithms in PET. In: Valk PE, Bailey DL, Townsend DW, Maisey MN (eds) Positron emission tomography: basic science and clinical practice. Springer, Berlin Heidelberg New York, pp 91–114Google Scholar
  9. Dizendorf EV, Baumert BG, Schulthess GK von, Lutolf UM, Steinert HC (2003) Impact of whole-body 18F-FDG PET on staging and managing patients for radiation therapy. J Nucl Med 44:24–29PubMedGoogle Scholar
  10. Erdi YE, Mawlawi O, Larson SM, Imbriaco M, Yeung H, Finn R, Humm JL (1997) Segmentation of lung lesion volume by adaptive positron emission tomography image thresholding. Cancer 80:2505–2509PubMedCrossRefGoogle Scholar
  11. Eshappan J, Mutic S, Malyapa RS, Grigsby PW, Zoberi I, Dehdashti F, Miller TR, Bosch WR, Low DA (2004) Treatment planning guidelines regarding the use of CT/PET-guided IMRT for cervical carcinoma with positive para-aortic lymph nodes. Int J Radiat Oncol Biol Phys 58:1289–1297Google Scholar
  12. Ezzel GA, Galvin JM, Low D, Palta JR, Rosen I, Sharpe MB, Xia P, Xiao Y, Xing L, Yu CX (2003) Guidance document on delivery, treatment planning, and clinical implementation of IMRT: report of the IMRT Subcommittee of the AAPM Radiation Therapy Committee. Med Phys 30:2089–2115Google Scholar
  13. Gallagher BM, Fowler JS, Gutterson NI, MacGregor RR, Wan CN, Wolf AP (1978) Metabolic trapping as a principle of radiopharmaceutical design: some factors responsible for the biodistribution of [18F] 2-deoxy-2-fluoro-D-glucose. J Nucl Med 10:1154–1161Google Scholar
  14. Garcia-Ramirez JL, Mutic S, Dempsey JF, Low DA, Purdy JA (2002) Performance evaluation of an 85-cm bore X-ray computed tomography scanner designed for radiation oncology and comparison with current diagnostic CT scanners. Int J Radiat Oncol Biol Phys 52:1123–1131PubMedCrossRefGoogle Scholar
  15. Goitein M, Abrams M (1983) Multi-dimensional treatment planning I. Delineation of anatomy. Int J Radiat Oncol Biol Phys 9:777–787PubMedGoogle Scholar
  16. Goitein M, Abrams M, Rowell D, Pollari H, Wiles J (1983) Multidimensional treatment planning II. Beam’s eye-view, back projection, and projection through CT sections. Int J Radiat Oncol Biol Phys 9:789–797PubMedGoogle Scholar
  17. Grigsby PW, Perez CA, Chao KS, Herzog T, Mutch DG, Rader J (2001a) Radiation therapy for carcinoma of cervix with biopsy-proven positive para-aortic lymph nodes. Int J Radiat Oncol Biol Phys 49:733–738PubMedCrossRefGoogle Scholar
  18. Grigsby PW, Williamson JF, Chao KSC, Perez CA (2001b) Cervical tumor control evaluated with ICRU 38 reference volumes an integrated reference air kerma. Radiother Oncol 58:10–23CrossRefGoogle Scholar
  19. Grigsby PW, Siegel BA, Dehdashti F, Mutch DG (2003) Posttherapy surveillance monitoring of cervical cancerr by FDG-PET. Int J Radiat Oncol Biol Phys 55:907–913PubMedCrossRefGoogle Scholar
  20. Gross MW, Weber WA, Feldman HJ, Bartenstein P, Schwaiger M, Molls M (1998) The value of F-18-fluorodeoxyglucose PET for the 3-D radiation treatment planning for malignant gliomas. Int J Radiat Oncol Biol Phys 41:989–995PubMedCrossRefGoogle Scholar
  21. Hicks RJ, MacManus MP (2003) 18F-FDG PET in candidates for radiation therapy: Is it important and how do we validate its impact? J Nucl Med 44:30–32PubMedGoogle Scholar
  22. Jerusalem G, Hustinx R, Beguin Y, Fillet G (2003) PET scan imaging in oncology. Eur J Cancer 39:1525–1534PubMedCrossRefGoogle Scholar
  23. Klingenbeck Regn K, Schaller S, Flohr T, Ohnesorge B, Kopp AF, Baum U (1999) Subsecond multi-slice computed tomography: basics and applications. Eur J Radiol 31:110–124Google Scholar
  24. Lavely WC, Scarfone C, Cevikalp H, Rui L, Byrne DW, Cmelak AJ, Dawant B, Price RR, Hallahan DE, Fitzpatrick JM (2004) Phantom validation of coregistration of PET and CT for image-guided radiotherapy. Med Phys 31:1083–1092PubMedCrossRefGoogle Scholar
  25. Levivier M, Wikier D, Goldman S, David P, Matens T, Massager N, Gerosa M, Devriendt D, Desmedt F, Simon S, van Houtte P, Brotchi J (2000) Integration of the metabolic data of positron emission tomography in the dosimetry planning of radiosurgery with the gamma knife: early experience with brain tumors. J Neurosurg 93:233–238PubMedGoogle Scholar
  26. Ling CC, Humm J, Larson S, Amols H, Fuks Z, Leibel S, Koutcher JA (2000) Towards multidimensional radiotherapy (MDCRT): biological imaging and biological conformality. Int J Radiat Oncol Biol Phys 47:551–560PubMedCrossRefGoogle Scholar
  27. Low DA, Nystrom M, Kalinin E, Parikh P, Dempsey JF, Bradley JD, Mutic S, Wahab SH, Islam T, Christensen G, Politte DG, Whiting BR (2003) A method for the reconstruction of 4-dimensional synchronized CT scans acquired during free breathing. Med Phys 30:1254–1263PubMedGoogle Scholar
  28. MacManus MP, Hicks RJ, Ball DL, Kalff V, Matthews JP, Salminen E, Khaw P, Wirth A, Rischin D, McKenzie A (2001) F-18 Fluorodeoxyglucose positron emission tomography staging in radical radiotherapy candidates with nonsmall cell lung carcinoma. Cancer 92:886–895Google Scholar
  29. Mah K, Caldwell CB, Ung YC, Danjoux CE, Balogh JM, Ganguli SN, Ehrlich LE, Tirona R (2002) The impact of 18FDG-PET on target and critical organs in CT-based treatment planning of patients with poorly defined non-small cell lung carcinoma: a prospective study. Int J Radiat Oncol Biol Phys 52:339–350PubMedCrossRefGoogle Scholar
  30. Malyapa RS, Mutic S, Low DA, Zoberi I, Bosch WR, Miller TR, Grigsby PW (2002) Physiologic FDG-PET three dimensional brachytherapy treatment planning for cervical cancer. Int J Radiat Oncol Biol Phys 54:1140–1146PubMedGoogle Scholar
  31. Meikle SR, Badawi RD (2003) Quantitative techniques in PET. In: Valk PE, Bailey DL, Townsend DW, Maisey MN (eds) Positron emission tomography: basic science and clinical practice. Springer, Berlin Heidelberg New York, pp 115–146Google Scholar
  32. Miller TR, Grigsby PW (2002) Measurement of tumor volume by PET to evaluate prognosis in patients with advance cervical cancer treated by radiation therapy. Int J Radiat Oncol Biol Phys 53:353–359PubMedCrossRefGoogle Scholar
  33. Mutic S, Dempsey JF, Bosch WR, Low DA, Drzymala RE, Chao KSC, Goddu SM, Cutler PD, Purdy JA (2001) Multimodality image registration quality assurance for conformal three-dimensional treatment planning. Int J Radiat Oncol Biol Phys 51:255–260PubMedCrossRefGoogle Scholar
  34. Mutic S, Grigsby PW, Low DA, Dempsey JF, Harms WR Sr, Laforest R, Bosch WR, Miller TR (2002) PET guided three-dimensional treatment planning of intracavitary gynecologic implants. Int J Radiat Oncol Biol Phys 52:1104–1110PubMedCrossRefGoogle Scholar
  35. Mutic S, Palta JR, Butker E, Das IJ, Huq MS, Loo LD, Salter BJ, McCollough CH, van Dyk J (2003a), Quality assurance for CT simulators and the CT simulation process: report of the AAPM Radiation Therapy Committee Task Group no. 66. Med Phys 30:2762–2792PubMedCrossRefGoogle Scholar
  36. Mutic S, Malyapa RS, Grigsby PW, Dehdashti F, Miller TR, Zoberi I, Bosch WR, Esthappan J, Low DA (2003b) PET-guided IMRT treatment for cervical carcinoma with positive para-aortic lymph nodes: a dose escalation treatment planning study. Int J Radiat Oncol Biol Phys 55:28–35PubMedCrossRefGoogle Scholar
  37. National Electrical Manufacturers Association (NEMA) (1998) DICOM PS 3 (set).Digital Imaging Communictaions in Medicine (DICOM)Google Scholar
  38. Nuutinen J, Sonninen P, Lehikoinen P, Sutinen E, Valavaara R, Eronen E, Norrgard S, Kulmala J, Teras M, Minn H (2000) Radiotherapy treatment planning and long-term follow-up with [(11)C]methionine PET in patients with low-grade astrocytoma, Int J Radiat Oncol Biol Phys 48:43–52PubMedCrossRefGoogle Scholar
  39. Osman MM, Cohade C, Nakamoto Y, Marshall LT, Leal JP, Wahl RL (2003) Clinically significant inaccurate localization of lesions with PET/CT: frequency in 300 patients. J Nuc Med 44:240–243Google Scholar
  40. Perez CA, Purdy JA, Harms W, Gerber R, Grahm MV, Matthews JW, Bosch W, Drzymala R, Emami B, Fox S (1995) Three-dimensional treatment planning and conformal radiation therapy: preliminary evaluation. Radiother Oncol 36:32–43PubMedCrossRefGoogle Scholar
  41. Pieterman, RM, van Putten JW, Meuzelaar JJ, Mooyaart EL, Vaalburg W, Koeter GH, Fidler V, Pruim J, Groen HJ (2000) Preoperative staging of non-small-cell lung cancer with positron-emission tomography. N Engl J Med 343:254–261PubMedCrossRefGoogle Scholar
  42. Poncelet AJ, Lonneux M, Coche E, Weynand B, Noirhomme P (2001) PET-FDG enhances but does not replace preoperative surgical staging in non-small cell lung carcinoma. Eur J Cardiothorac Surg 20:468–474PubMedGoogle Scholar
  43. Purdy JA (1997) Advances in three-dimensional treatment planning and conformal dose delivery. Semin Oncol 24:655–671PubMedGoogle Scholar
  44. Sherouse GW, Novins K, Chaney EL (1990) Computation of digitally reconstructed radiographs for use in radiotherapy treatment design. Int J Radiat Oncol Biol Phys 18:651–658PubMedGoogle Scholar
  45. Steinert HC, Hauser M, Allemann F, Engel H, Berthold T, Schulthess GK von, Weder W (1997) Non-small cell lung cancer: nodal staging with FDG PET versus CT with corelative lymph node mapping and sampling. Radiology 202:441–446PubMedGoogle Scholar
  46. Strauss LG (2004) Fluorine-18 deoxygluocose and false-positive results: a major problem in the diagnostics of oncological patients. Eur J Nucl Med 23:1409–1415Google Scholar
  47. Townsend DW, Carney JP, Yap JT, Hall NC (2004) PET/CT today and tomorrow. J Nucl Med 45 (Suppl 1):4S–14SPubMedGoogle Scholar
  48. Valk PE, Bailey DL, Townsend DW, Maisey MN (eds) (2002) Positron emission tomography: basic science and clinical practice. Springer, Berlin Heidelberg New YorkGoogle Scholar
  49. Weissleder R, Mahmood U (2001) Melecular imaging. Radiology 219:316–333PubMedGoogle Scholar
  50. Young H, Baum R, Cremerius U, Herholz K, Hoekstra O, Lammertsma AA, Pruim J, Price P (1999) Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations. European Organization for Research and Treatment of Cancer (EORTC) PET Study Group. Eur J Cancer 13:1773–1782Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2006

Authors and Affiliations

  • Sasa Mutic
    • 1
  1. 1.Mallinckrodt Institute of Radiology, Siteman Cancer CenterWashington University School of MedicineSt. LouisUSA

Personalised recommendations